Ohana & Co advised RéVive Skincare on its acquisition by S’Young Group, a prominent beauty conglomerate based in Changsha, China.
Launched in 1997, RéVive Skincare is a luxury skincare line developed by Dr. Gregory Bays Brown, a plastic and reconstructive surgeon, created to bring back the glow of youth. Each product has been scientifically formulated with Bio-Renewal Technology, inspired by patented and Nobel Prize–winning science that Dr. Brown used to heal burn victims. This breakthrough technology delivers fast results to help change the behavior of skin and restore skin’s youthful glow. RéVive is distributed domestically at luxury retailers Neiman Marcus, Saks, Bergdorf Goodman, Bluemercury, and Cos Bar, and select retailers in Canada, UK, Europe, and Asia.Tengram Capital Partners, which acquired RéVive from Shiseido in 2017, oversaw the appointment of Elana Drell Szyfer as CEO and John Elmer as CFO and COO. Under the new ownership, Dr. Brown and the management team will retain their roles, and RéVive will continue to operate independently.
In addition to being one of the most successful manufacturers of facial mask brands in China, the S’Young Group is also the online distributor for beauty brands including Johnson & Johnson China, Fenty Beauty, Dr. Ci:Labo, Albion, Neutrogena, Kiko, and Lumene. Sales for the company overall were estimated to be $640.5 million in 2023.
Ohana & Co acted as the exclusive financial advisor to RéVive in this transaction.